Immunocore

NASDAQ: IMCR · Real-Time Price · USD
37.26
-0.76 (-2.00%)
At close: Jun 06, 2025, 3:59 PM
37.30
0.11%
After-hours: Jun 06, 2025, 04:05 PM EDT

Immunocore Revenue Breakdown

Period Ending Dec 31, 2024
Collaboration Revenue Revenue 213K
Collaboration Revenue Revenue Growth n/a

Revenue by Geography

Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Europe Revenue 73.22M 67.63M 35.49M 3.01M
Europe Revenue Growth +8.27% +90.56% +1079.07% n/a
International Revenue 10.08M 169.79M n/a n/a
International Revenue Growth -94.06% n/a n/a n/a
United States Revenue 226.69M n/a n/a n/a
United States Revenue Growth n/a n/a n/a n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019
Selling, General, and Administrative Revenue 40.2M 42.32M 35.53M 38.64M 39.29M 57.13M 13.37M 45.6M 41.16M 43.14M 25.88M 24.51M 20.11M 24.37M 20.05M 23.8M 20.18M 14.17M 9.71M 12.25M 9.61M 8.57M
Selling, General, and Administrative Revenue Growth -5.02% +19.12% -8.04% -1.65% -31.23% +327.39% -70.69% +10.78% -4.59% +66.68% +5.59% +21.91% -17.48% +21.54% -15.77% +17.92% +42.43% +45.88% -20.70% +27.54% +12.05% n/a
Research and Development Revenue 56.47M 60.85M 52.77M 51.07M 57.46M 74.65M 38.53M 36.43M 35.16M 27.14M 23.3M 20.15M 18.58M 20.07M 16.8M 16.47M 19.89M 17.24M 20.41M 16.38M 20.78M 24.58M
Research and Development Revenue Growth -7.20% +15.31% +3.32% -11.12% -23.03% +93.74% +5.77% +3.59% +29.58% +16.47% +15.64% +8.44% -7.43% +19.49% +1.99% -17.17% +15.32% -15.51% +24.61% -21.18% -15.45% n/a